“We are deeply concerned by the critical COVID-19 situation in India, and our hearts go out to you, your loved ones and all the people of India,” says Pfizer Chairman and CEO Albert Bourla
Global pharma major Pfizer is sending its medicines worth $70 million (over ₹510 crore), from its distribution centres in the U.S., Europe and Asia, that have been identified as part of India’s COVID-19 treatment protocol, the company’s Chairman and CEO Albert Bourla said on May 3.